Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Recombinant human erythropoietin (rhuEPO) has been extensively used as a pharmaceutical product for treating anemia in the clinic. Glycosylation of rhuEPO was crucial for affecting biological activity, immunogenicity, and pharmacokinetics. Because of the heterogeneity of glycan, the structure of rhuEPO was complex with several isoforms. Characterization of isoforms was important for quality control of rhuEPO. This service provides an improved cIEF method for the isoforms analysis of recombinant human erythropoietin.